{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:54:16Z","timestamp":1781556856046,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bbrc.2026.153979","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T22:42:05Z","timestamp":1779230525000},"page":"153979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Aloe-emodin ameliorates non-alcoholic fatty liver disease by regulating the ZNRF3\/Wnt\/\u03b2-catenin axis and suppressing hepatic lipogenesis"],"prefix":"10.1016","volume":"827","author":[{"given":"Wenjuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meimin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.bbrc.2026.153979_bib1","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1097\/CM9.0000000000002277","article-title":"Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis","volume":"135","author":"Liu","year":"2022","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"10.1016\/j.bbrc.2026.153979_bib2","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIRCRESAHA.121.319059","article-title":"Nonalcoholic fatty liver disease: an emerging driver of cardiac arrhythmia","volume":"128","author":"Chen","year":"2021","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153979_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100556","article-title":"Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C","volume":"27","author":"Golabi","year":"2022","journal-title":"Ann. Hepatol."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153979_bib4","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.gastro.2022.06.023","article-title":"AGA clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: expert review","volume":"163","author":"Long","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2026.153979_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1081096","article-title":"Effects of lifestyle intervention on adults with metabolic associated fatty liver disease: a systematic review and meta-analysis","volume":"14","author":"Chai","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153979_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbrc.2026.153979_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114319","article-title":"Protopanaxadiol ameliorates NAFLD by regulating hepatocyte lipid metabolism through AMPK\/SIRT1 signaling pathway","volume":"160","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153979_bib8","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2026.153979_bib9","article-title":"TMEM88 modulates lipid synthesis and metabolism cytokine by regulating Wnt\/beta-catenin signaling pathway in non-alcoholic fatty liver disease","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.bbrc.2026.153979_bib10","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1111\/cas.15883","article-title":"FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt\/beta-catenin pathway","volume":"114","author":"Lu","year":"2023","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153979_bib11","doi-asserted-by":"crossref","DOI":"10.26599\/FMH.2024.9420015","article-title":"Identification and mechanism elucidation of medicative diet for food therapy XQCSY in NAFLD prevention: an integrative in silico study","volume":"1","author":"Ren","year":"2024","journal-title":"Food & Medicine Homology"},{"issue":"6","key":"10.1016\/j.bbrc.2026.153979_bib12","first-page":"1312","article-title":"Qinfei xiegan decoction in treatment of type 2 diabetes with non-alcoholic fatty liver","volume":"2020","author":"Yadong Liu","year":"2020","journal-title":"Acta Chinese Medicine"},{"issue":"18","key":"10.1016\/j.bbrc.2026.153979_bib13","first-page":"83","article-title":"Regulatory effect of Qingfei Xiegan Tang on inflammatory response and intestinal flora of type 2 diabetes mellitus","volume":"2019","author":"Congshu Dai","year":"2019","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"issue":"3","key":"10.1016\/j.bbrc.2026.153979_bib14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1142\/S0192415X16500300","article-title":"Attenuates high fat diet-induced hepatosteatosis by activating AMP-activated protein kinase","volume":"44","author":"Yang","year":"2016","journal-title":"Am. J. Chin. Med."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153979_bib15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12967-022-03495-4","article-title":"Rhubarb free anthraquinones improved mice nonalcoholic fatty liver disease by inhibiting NLRP3 inflammasome","volume":"20","author":"Wu","year":"2022","journal-title":"J. Transl. Med."},{"issue":"7","key":"10.1016\/j.bbrc.2026.153979_bib16","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1248\/cpb.54.941","article-title":"Development of a high performance liquid chromatographic method for systematic quantitative analysis of chemical constituents in rhubarb","volume":"54","author":"Komatsu","year":"2006","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.bbrc.2026.153979_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/6318520","article-title":"Aloe emodin reduces cardiac inflammation induced by a high-fat diet through the TLR4 signaling pathway","volume":"2020","author":"Chen","year":"2020","journal-title":"Mediat. Inflamm."},{"issue":"8","key":"10.1016\/j.bbrc.2026.153979_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/jbt.21415","article-title":"Aloe-emodin inhibits adipocyte differentiation and maturation during in vitro human mesenchymal stem cell adipogenesis","volume":"26","author":"Subash-Babu","year":"2012","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"14","key":"10.1016\/j.bbrc.2026.153979_bib19","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.febslet.2010.06.004","article-title":"Aloe emodin glycosides stimulates glucose transport and glycogen storage through PI3K dependent mechanism in L6 myotubes and inhibits adipocyte differentiation in 3T3L1 adipocytes","volume":"584","author":"Anand","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2026.153979_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1238841","article-title":"Exploring the mechanism of aloe-emodin in the treatment of liver cancer through network pharmacology and cell experiments","volume":"14","author":"Zhu","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.bbrc.2026.153979_bib21","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1002\/ptr.6471","article-title":"The anti-hepatitis B virus therapeutic potential of anthraquinones derived from Aloe vera","volume":"33","author":"Parvez","year":"2019","journal-title":"Phytother Res."},{"issue":"5","key":"10.1016\/j.bbrc.2026.153979_bib22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4093\/dmj.2021.0197","article-title":"Rho-kinase as a therapeutic target for nonalcoholic fatty liver diseases","volume":"45","author":"Sousa-Lima","year":"2021","journal-title":"Diabetes Metab. J"},{"issue":"18","key":"10.1016\/j.bbrc.2026.153979_bib23","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153979_bib24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.livres.2023.11.003","article-title":"In-depth analysis of de novo lipogenesis in non-alcoholic fatty liver disease: mechanism and pharmacological interventions","volume":"7","author":"Zhu","year":"2023","journal-title":"Liver Res"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153979_bib25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cld.2023.01.013","article-title":"Pathogenetic pathways in nonalcoholic fatty liver disease: an incomplete jigsaw puzzle","volume":"27","author":"Pan","year":"2023","journal-title":"Clin. Liver Dis."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153979_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.hbpd.2022.10.003","article-title":"Wnt\/beta-catenin signaling and its modulators in nonalcoholic fatty liver diseases","volume":"22","author":"Shree Harini","year":"2023","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.bbrc.2026.153979_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113942","article-title":"Pyrvinium pamoate attenuates non-alcoholic steatohepatitis: insight on hedgehog\/Gli and Wnt\/beta-catenin signaling crosstalk","volume":"177","author":"El-Derany","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.bbrc.2026.153979_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11070926","article-title":"Wnt\/beta-Catenin signaling in liver cancers","volume":"11","author":"Wang","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbrc.2026.153979_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1289004","article-title":"Wnt\/beta-catenin signaling activation promotes lipogenesis in the steatotic liver via physical mTOR interaction","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.bbrc.2026.153979_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-pathol-020117-044010","article-title":"Wnt\/beta-Catenin signaling in liver development, homeostasis, and pathobiology","volume":"13","author":"Russell","year":"2018","journal-title":"Annu. Rev. Pathol."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153979_bib31","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1097\/HEP.0000000000000495","article-title":"Wnt-beta-catenin in hepatobiliary homeostasis, injury, and repair","volume":"78","author":"Nejak-Bowen","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2026.153979_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.970292","article-title":"The AMPK pathway in fatty liver disease","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Physiol."},{"issue":"7","key":"10.1016\/j.bbrc.2026.153979_bib33","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.14218\/JCTH.2023.00334","article-title":"An overview of the role of peroxisome proliferator-activated receptors in liver diseases","volume":"11","author":"Changizi","year":"2023","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153979_bib34","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1097\/HEP.0000000000000495","article-title":"Wnt-\u03b2-catenin in hepatobiliary homeostasis, injury, and repair","volume":"78","author":"Nejak-Bowen","year":"2023","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153979_bib35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-0033-1358523","article-title":"Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP","volume":"33","author":"Xu","year":"2013","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbrc.2026.153979_bib36","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1038\/ncomms3787","article-title":"Structural and molecular basis of ZNRF3\/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin","volume":"4","author":"Zebisch","year":"2013","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153979_bib37","doi-asserted-by":"crossref","first-page":"376","DOI":"10.15283\/ijsc23070","article-title":"RNF43 and ZNRF3 in wnt signaling - a master regulator at the membrane","volume":"16","author":"Farnhammer","year":"2023","journal-title":"Int. J. Stem Cells"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153979_bib38","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41467-021-27923-z","article-title":"RNF43\/ZNRF3 loss predisposes to hepatocellular-carcinoma by impairing liver regeneration and altering the liver lipid metabolic ground-state","volume":"13","author":"Belenguer","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153979_bib39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ajpath.2022.10.008","article-title":"Loss of hepatic leucine-rich repeat-containing G-Protein coupled receptors 4 and 5 promotes nonalcoholic fatty liver disease","volume":"193","author":"Saponara","year":"2023","journal-title":"Am. J. Pathol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26007436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26007436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T20:21:54Z","timestamp":1781554914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26007436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":39,"alternative-id":["S0006291X26007436"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153979","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aloe-emodin ameliorates non-alcoholic fatty liver disease by regulating the ZNRF3\/Wnt\/\u03b2-catenin axis and suppressing hepatic lipogenesis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153979"}}